{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:54:01Z","timestamp":1792090441534,"version":"4.4.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background and Objectives:<\/jats:title>\n                    <jats:p>Neurocysticercosis (NCC) due to Taenia Solium is a major public health problem. Our objective was to study patients with disseminated cysticercosis (DCC) who had NCC in the brain along with an additional site in the body and assess their clinical, radiological profile, and response to therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A chart review of DCC with a high lesion load of NCC \u226520 (DNCC) in the brain was performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Sixteen (M:F = 13:3) patients were diagnosed with DNCC with a mean age of presentation of 35.1 \u00b1 14.2 years. Headache was the predominant symptom, followed by seizures (93.75%), vomiting (43.75%), behavioral disturbances (31.25%), fever (12.5%), encephalopathy (12.5%), visual disturbances (6.25%), and muscle pain and limb weakness (6.25%). CT brain showed multiple active parenchymal cysts in all, and calcifications in 68.75%. MRI brain revealed involvement of cortex and subcortical structures in all, followed by cerebellum (81.25%) and brainstem (75%). Intramedullary spinal lesion was observed in 12.5% cases. Albendazole with steroids was used in 15 patients. In 93.3% patients, there was complete improvement in seizures; 12.5% subjects had persistent memory and behavioral abnormalities. One subject required decompressive craniectomy; mortality was observed in two subjects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>We hereby report one of the largest case series on disseminated cysticercosis with a high lesion load of NCC in the brain. A comprehensive clinical, imaging, therapeutic response with repeat imaging and long-term follow-up has given us a better understanding of this difficult-to-treat neurological disorder. We suggest cautious use of anti-parasitic therapy under the cover of corticosteroids to prevent irreversible neurological sequelae.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0028-3886.349634","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T03:55:57Z","timestamp":1692849357000},"page":"1032-1040","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Disseminated Cysticercosis in Indian Scenario \u2013 Experience from a Teaching University Hospital"],"prefix":"10.4103","volume":"70","author":[{"given":"Harikrishna V","family":"Ganaraja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Mahadevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitender","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atchayaram","family":"Nalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod K","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parthasarathy","family":"Satishchandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjunath","family":"Netravathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-31-20241013","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1148\/rg.306105522","article-title":"Neurocysticercosis: Radiologic-pathologic correlation","volume":"30","author":"Kimura-Hayama","year":"2010","journal-title":"Radiographics"},{"key":"R2-31-20241013","doi-asserted-by":"crossref","first-page":"e1500","DOI":"10.1371\/journal.pntd.0001500","article-title":"Neurocysticercosis: Neglected but not forgotten","volume":"6","author":"Coyle","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"R3-31-20241013","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4103\/0971-5916.198686","article-title":"Neurocysticercosis: Diagnostic problems and current therapeutic strategies","volume":"144","author":"Rajshekhar","year":"2016","journal-title":"Indian J Med Res"},{"key":"R4-31-20241013","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4269\/ajtmh.2012.12-0162","article-title":"Massive neurocysticercosis: Encephalitic versus non-encephalitic","volume":"87","author":"Del Brutto","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"R5-31-20241013","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1259\/bjr\/43104295","article-title":"Pulmonary and cardiac cysticercosis: Helical CT findings","volume":"80","author":"Bastos","year":"2007","journal-title":"Br J Radiol"},{"key":"R6-31-20241013","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1179\/2047773212Y.0000000025","article-title":"Diagnostic criteria for neurocysticercosis, revisited","volume":"106","author":"Del Brutto","year":"2012","journal-title":"Pathog Glob Health"},{"key":"R7-31-20241013","doi-asserted-by":"crossref","first-page":"e4882","DOI":"10.1097\/MD.0000000000004882","article-title":"Disseminated cysticercosis: Clinical spectrum, Toll-like receptor-4 gene polymorphisms and role of Albendazole","volume":"95","author":"Qavi","year":"2016","journal-title":"Medicine (Baltimore"},{"key":"R8-31-20241013","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CMR.15.4.747-756.2002","article-title":"Current consensus guidelines for treatment of neurocysticercosis","volume":"15","author":"Garcia","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"R9-31-20241013","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/2278-344X.187831","article-title":"Human cysticercosis","volume":"5","author":"Chandra","year":"2016","journal-title":"Int J Health Allied Sci"},{"key":"R10-31-20241013","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.4103\/0028-3886.190237","article-title":"Disseminated cysticercosis","volume":"64","author":"Sardana","year":"2016","journal-title":"Neurol India"},{"key":"R11-31-20241013","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4103\/0028-3886.222855","article-title":"Disseminated cysticercosis presenting as status epilepticus, rhabdomyolysis, and acute kidney injury: An unreported complication","volume":"66","author":"Vikranth","year":"2018","journal-title":"Neurol India"},{"key":"R12-31-20241013","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/2229-5070.105183","article-title":"A rare case of disseminated cysticercosis","volume":"2","author":"Bothale","year":"2012","journal-title":"Trop Parasitol"},{"key":"R13-31-20241013","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/0972-2327.78054","article-title":"A case of disseminated neurocysticercosis","volume":"14","author":"Saranya","year":"2011","journal-title":"Ann Indian Acad Neurol"},{"key":"R14-31-20241013","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4269\/ajtmh.12-0355","article-title":"A rare case of disseminated cysticercosis and Taeniasis in a Japanese traveller after returning from India","volume":"89","author":"Kobayashi","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"R15-31-20241013","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4103\/1755-6783.120994","article-title":"Disseminated cysticercosis: Uncommon presentation of a common disease","volume":"6","author":"Dhar","year":"2013","journal-title":"Ann Trop Med Public Health"},{"key":"R16-31-20241013","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1474-4422(05)70194-0","article-title":"Neurocysticercosis: Updated concepts about an old disease","volume":"4","author":"Garcia","year":"2005","journal-title":"Lancet Neurol"},{"key":"R17-31-20241013","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1016\/j.ijid.2012.12.010","article-title":"Corticosteroids for neurocysticercosis: A systematic review and meta-analysis of randomized controlled trials","volume":"17","author":"Cuello-Garc\u00eda","year":"2013","journal-title":"Int J Infect Dis"},{"key":"R18-31-20241013","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12879-020-4891-5","article-title":"Quantitative assessment of lesion load and efficacy of 3 cycles of albendazole in disseminated cysticercosis: A prospective evaluation","volume":"20","author":"Pandey","year":"2020","journal-title":"BMC Infect Dis"},{"key":"R19-31-20241013","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0035-9203(89)90509-9","article-title":"Neurocysticercosis: Treatment with albendazole and dextrochloropheniramine","volume":"83","author":"Agapejev","year":"1989","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R20-31-20241013","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1086\/511040","article-title":"Methotrexate as a corticosteroid-sparing agent in complicated neurocysticercosis","volume":"44","author":"Mitre","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R21-31-20241013","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/111.3.597","article-title":"Disseminated cysticercosis. New observations, including CT scan findings and experience with treatment by praziquantel","volume":"111","author":"Wadia","year":"1988","journal-title":"Brain"},{"key":"R22-31-20241013","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ajp.2013.01.013","article-title":"Neuropsychiatric manifestations and treatment of disseminated neurocysticercosis: A compilation of three cases","volume":"6","author":"Shah","year":"2013","journal-title":"Asian J Psychiatr"},{"key":"R23-31-20241013","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMoa031294","article-title":"A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis","volume":"350","author":"Garcia","year":"2004","journal-title":"N Engl J Med"},{"key":"R24-31-20241013","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1473-3099(14)70779-0","article-title":"Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: A double-blind, randomized controlled trial","volume":"14","author":"Garcia","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R25-31-20241013","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1093\/cid\/cix1084","article-title":"Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"66","author":"White","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R26-31-20241013","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/jnnp.2008.144899","article-title":"Effects of albendazole treatment on neurocysticercosis: A randomised controlled trial","volume":"79","author":"Carpio","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R27-31-20241013","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1007\/s00436-013-3459-3","article-title":"Antiparasitic treatment of cerebral cysticercosis: Lessons and experiences from China","volume":"112","author":"Wu","year":"2013","journal-title":"Parasitol Res"},{"key":"R28-31-20241013","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1473-3099(15)70031-9","article-title":"Combined antiparasitic treatment for neurocysticercosis","volume":"15","author":"Mahamat","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"R29-31-20241013","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4269\/ajtmh.18-0795","article-title":"Etanercept to control inflammation in the treatment of complicated neurocysticercosis","volume":"100","author":"Nash","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"R30-31-20241013","first-page":"43","article-title":"Case of cysticercus cellulose","volume":"27","author":"Krishnaswami","year":"1912","journal-title":"Ind Med Gaz"}],"container-title":["Neurology India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.349634","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:18:32Z","timestamp":1787836712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.349634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/0028-3886.349634","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]}}}